首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Intra-articular delivery of genipin cross-linked chitosan microspheres of flurbiprofen: Preparation, characterization, in vitro and in vivo studies
【24h】

Intra-articular delivery of genipin cross-linked chitosan microspheres of flurbiprofen: Preparation, characterization, in vitro and in vivo studies

机译:genbiin交联的氟比洛芬壳聚糖微球的关节内递送:制备,表征,体外和体内研究

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, genipin cross-linked chitosan microspheres of flurbiprofen for intra-articular (i.a.) delivery were prepared. Emulsion-cross-linking method was used to prepare the microspheres using different concentrations of genipin and drug-to-polymer ratios. The mean particle size was found to be in the range of 5.18-9.74 μm with good % drug entrapment up to 80.97%. SEM indicated the spherical shape with smooth surface of drug-loaded cross-linked microspheres. FTIR confirmed cross-linking of genipin with chitosan and the absence of chemical interactions between drug, polymer, and cross-linker, which was further confirmed by TGA showing unaltered melting point of entrapped drug. DSC and XRD revealed the molecular dispersion of drug within microspheres. The optimized microspheres were able to release the drug for more than 108 h. The biocompatibility of the microspheres in the rat (Sprague-Dawley) knee joints was confirmed by histopathology. The results of pharmacokinetic study, decreased K a and T max, lower C max and AUC (0-24) and delayed MRT, suggested the significant extended release of flurbiprofen from microspheres in comparison with its solution at P 0.05. The recovery of flurbiprofen as the percent of administered dose followed by 24 h after i.a. injection of microspheres was found to be 8.7 folds higher than its solution.
机译:在这项研究中,制备了氟比洛芬的Genipin交联的壳聚糖微球用于关节内(i.a.)递送。使用乳液交联法使用不同浓度的Genipin和药物与聚合物的比例来制备微球。发现平均粒径在5.18-9.74μm的范围内,良好的药物截留率高达80.97%。 SEM表明载药的交联微球具有光滑表面的球形。 FTIR证实了Genipin与壳聚糖的交联以及药物,聚合物和交联剂之间不存在化学相互作用,而TGA进一步证实了其所捕获药物的熔点不变。 DSC和XRD揭示了药物在微球内的分子分散。优化的微球能够释放药物超过108小时。通过组织病理学证实了大鼠(Sprague-Dawley)膝关节中微球的生物相容性。药代动力学研究的结果是,K a和T max降低,C max和AUC降低(0-24)以及MRT延迟,表明氟比洛芬从微球体中的释放与其溶液相比显着延长释放,P <0.05。氟比洛芬的恢复以给药剂量的百分比表示,随后在i.a.后24小时发现微球的注射量比其溶液高8.7倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号